ARCHIVES

Samuel Waksal Resigns From ImClone Following Unimpressive ASCO Presentation

This article is from The Cancer Letter archive.

Vol. 28 No. 21 | May 24, 2002

Download PDF Visit The Full Archive

Related Articles

Vermont Cancer Center’s NCI Core Grant Renewed.

May 11, 2001

Complaints Are “Astonishingly Far From Facts,” But NCI May Be Leaving Good Science Unfunded

April 29, 1977

ODAC Prefers Three-Hour Taxol Infusion. Says Data Dosage Still Uncertain

October 1, 1993

Cancer Meetings Listed

March 26, 1993

HPV DNA Testing Reduced Cervical Cancer Precursors

September 24, 2010

Study Finds Hormonal Therapy Reduces Risk Of Disease Progression In Prostate Cancer

July 27, 2001